These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3052153)

  • 1. [Pharmacologic modification of vigilance in the postnarcotic phase-- naloxone or physostigmine?].
    Schneck HJ; Tempel G; von Hundelshausen B
    Anasth Intensivther Notfallmed; 1988 Aug; 23(4):209-13. PubMed ID: 3052153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Modification of vigilance in the postanesthetic phase using physostigmine].
    Schneck HJ; von Hundelshausen B; Tempel G; Brosch R
    Anaesthesist; 1985 Sep; 34(9):456-61. PubMed ID: 3909841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antagonists in anesthesia].
    Lauven PM; Calaminus JM
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1995 Oct; 30(6):331-6. PubMed ID: 8541433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Postoperative routine use of physostigmine on vigilance, cardiovascular parameters and need of analgesics].
    Latasch L; Müller B; Freye E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Aug; 38(8):528-37. PubMed ID: 12905110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Postoperative reversal of loss of vigilance following midazolam with the use of the antagonist flumazenil (Ro 15-1788). A comparative study with a placebo and the use of EEG-power spectra].
    Freye E; Fournell A
    Anaesthesist; 1988 Mar; 37(3):162-6. PubMed ID: 3132866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nalbuphine following fentanyl. Postoperative analgesia].
    Schaer H; Baasch K; Achtari R
    Anaesthesist; 1987 Apr; 36(4):166-71. PubMed ID: 3300408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of postoperative opioid-induced respiratory depression: nalbuphine versus naloxone.
    Bailey PL; Clark NJ; Pace NL; Stanley TH; East KA; van Vreeswijk H; van de Pol P; Clissold MA; Rozendaal W
    Anesth Analg; 1987 Nov; 66(11):1109-14. PubMed ID: 3662056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ketamine racemate versus S-(+)-ketamine with or without antagonism with physostigmine. A quantitative EEG study on volunteers].
    Engelhardt W; Stahl K; Marouche A; Hartung E; Dierks T
    Anaesthesist; 1994 Nov; 43 Suppl 2():S76-82. PubMed ID: 7840418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of physostigmine on arousal, respiration and circulation--double-blind studies].
    Matsuda I; Ohtake K; Yoshizawa M; Sato K; Ikeda K; Suzuki K; Kawakage I; Fujii K
    Masui; 1982 Aug; 31(8):865-71. PubMed ID: 6754987
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversal of sedation and respiratory depression after anaesthesia by the combined use of physostigmine and naloxone in neurosurgical patients.
    Wiklund L
    Acta Anaesthesiol Scand; 1986 Jul; 30(5):374-7. PubMed ID: 3766092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of pentazocine, naloxone and morphine in opioid-dependent volunteers.
    Lamas X; Farre M; Cami J
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1485-92. PubMed ID: 8138958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physostigmine, naloxone, narcotics and sedatives in patients recovering from general anesthesia.
    Havasi I; Havasi G; Gintautas J; Kilaru N; Racz GB
    Proc West Pharmacol Soc; 1981; 24():27-8. PubMed ID: 7255466
    [No Abstract]   [Full Text] [Related]  

  • 13. [Demonstration of bencyclane effects in a clinico-pharmacologic vigilance model].
    Herrmann WM; Kern U
    Z Gerontol; 1984; 17(5):261-70. PubMed ID: 6395526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 5-hydroxytryptamine 4 receptor agonist mosapride does not antagonize morphine-induced respiratory depression.
    Lötsch J; Skarke C; Schneider A; Hummel T; Geisslinger G
    Clin Pharmacol Ther; 2005 Sep; 78(3):278-87. PubMed ID: 16153398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of nalbuphine to antagonize morphine: a double-blind comparison with naloxone.
    Bailey PL; Clark NJ; Pace NL; Isern M; Stanley TH
    Anesth Analg; 1986 Jun; 65(6):605-11. PubMed ID: 3085551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period.
    Correia CJ; Walsh SL; Bigelow GE; Strain EC
    Psychopharmacology (Berl); 2006 Dec; 189(3):297-306. PubMed ID: 17013637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modification of postoperative somnolence following halothane anesthesia by physostigmine].
    Hartung HJ; Osswald PM; Puhl R; Jacoby R
    Anasth Intensivther Notfallmed; 1986 Apr; 21(2):82-4. PubMed ID: 3728891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal agents in sedation and anesthesia: a review.
    Anderson JA
    Anesth Prog; 1988; 35(2):43-7. PubMed ID: 3137841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of naloxone or physostigmine to reverse nitrogen anesthesia in guinea pigs.
    Nicodemus HF; McElroy H
    Undersea Biomed Res; 1981 Sep; 8(3):171-4. PubMed ID: 7292786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Opioid detoxication under general anesthesia].
    Zemtsovski MJ; Trosko O; Schmidt H
    Ugeskr Laeger; 2002 Sep; 164(36):4165-9. PubMed ID: 12362827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.